RGL-193 Putamen Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RGL-193 Putamen Injection, covering 2025-12-12 to 2025-12-12. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease